Table 3 ME/CFS and Long COVID Improvement in Physical and Mental Fatigue
ME/CFS % Fatigue Improvement From Baseline | |||||
|---|---|---|---|---|---|
500 mg BID N = 23 | Overall Likert Score | Overall Bimodal Score | Treated % at or Below 4 on Bimodal | Physical Fatigue | Mental Fatigue |
2-Weeks | 18.1%* | 25.0%*** | 21.7%* | 16.1%*** | 19.4%*** |
6-Weeks | 22.5%*** | 23.7%*** | 21.7%* | 17.3%*** | 17.5%*** |
1000 mg BID N = 29 | Overall Likert Score | Overall Bimodal Score | Treated % at or Below 4 on Bimodal | Physical Fatigue | Mental Fatigue |
|---|---|---|---|---|---|
2-Weeks | 16.3%** | 19.7%*** | 17.1%* | 18.7%*** | 20.5%*** |
6-Weeks | 27.9%*** | 30.8%*** | 27.6%*** | 29.8%*** | 25.9%*** |
1000 mg TID N = 24 | Overall Likert Score | Overall Bimodal Score | Treated % at or Below 4 on Bimodal | Physical Fatigue | Mental Fatigue |
|---|---|---|---|---|---|
2-Weeks | 18.5%** | 14.3%* | 16.7%* | 13.1%* | 13.6%* |
6-Weeks | 23.3%*** | 26.7%** | 33.3%** | 24.3%** | 18.6%* |
Long COVID Improvement Over Baseline | ||||||
|---|---|---|---|---|---|---|
Chalder Fatigue at 6 Weeks | ||||||
2-Weeks | 6-Weeks | Physical | Mental | Bimodal | 4 or Below | |
500 mg BID | 34.6%*** | 36%*** | 33.5%*** | 23.1%*** | 46.8%*** | 45.5%*** |
1000 mg BID | 17.8%* | 25.3%*** | 15%* | 2.60% | 20.7%* | 23.8%** |